Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New tool aims to ease tough choices for sarcoma patients

NCT ID NCT05741944

First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 27 times

Summary

This study looks at whether a personalized risk assessment tool called PERSARC can help adults with soft-tissue sarcoma understand their treatment options better and feel less conflicted about their decisions. About 120 patients will either receive standard care or use the tool during doctor visits. The goal is to see if the tool improves knowledge and reduces regret.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Erasmus MC

    Rotterdam, South Holland, 3015GD, Netherlands

  • Leiden University Medical Center

    Leiden, South Holland, 2333ZA, Netherlands

  • Maastricht UMC

    Maastricht, Limburg, 6229HX, Netherlands

  • Netherlands Cancer Institue

    Amsterdam, North Holland, 1066CX, Netherlands

  • Radboud UMC

    Nijmegen, Gelderland, 6525GA, Netherlands

  • UMC Groningen

    Groningen, Provincie Groningen, 9713GZ, Netherlands

  • UMC Utrecht

    Utrecht, Utrecht, 3584CX, Netherlands

Conditions

Explore the condition pages connected to this study.